Zoetis says 25% of Simparica Trio-treated dogs had adult heartworms vs. 75% on NexGard Plus in drug-resistant heartworm study

Zoetis says in a drug-resistant heartworm study, 25% of dogs treated with Simparica Trio had adult heartworms versus 75% on NexGard Plus.

Detected & updated continuously · Source: Nebula

Story subjects

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula